Page last updated: 2024-08-18

cyclohexanol and alprazolam

cyclohexanol has been researched along with alprazolam in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, SX; Fogelman, SM; Greenblatt, DJ; Harmatz, JS; Schmider, J; Shader, RI; von Moltke, LL1
Albano, D; Amchin, J; Klockowski, PM; Taylor, KP; Zarycranski, W1
Ninan, PT1
Rickels, K; Rynn, M1
Cheng, KT; DeVane, CL; Donovan, JL; Liston, HL; Markowitz, JS; Risch, SC; Willard, L1
Christodoulou, C; Douzenis, A; Lykouras, L; Michopoulos, I1
Badin, J; Bretaudeau Deguigne, M; Francino, MC; Perrotin, D; Turcant, A1

Reviews

1 review(s) available for cyclohexanol and alprazolam

ArticleYear
Pharmacotherapy of generalized anxiety disorder.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 14

    Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Paroxetine; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

2002

Trials

2 trial(s) available for cyclohexanol and alprazolam

ArticleYear
Effect of venlafaxine on the pharmacokinetics of alprazolam.
    Psychopharmacology bulletin, 1998, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Drug Interactions; Female; Humans; Male; Venlafaxine Hydrochloride

1998
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; Alprazolam; Area Under Curve; Breath Tests; Carbon Radioisotopes; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Administration Schedule; Erythromycin; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Molecular Probes; Piperazines; Sertraline; Triazoles; Venlafaxine Hydrochloride

2004

Other Studies

4 other study(ies) available for cyclohexanol and alprazolam

ArticleYear
Venlafaxine and metabolites are very weak inhibitors of human cytochrome P450-3A isoforms.
    Biological psychiatry, 1997, Feb-01, Volume: 41, Issue:3

    Topics: Alprazolam; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; GABA Modulators; Humans; In Vitro Techniques; Isoenzymes; Microsomes, Liver; Oxidoreductases, N-Demethylating; Venlafaxine Hydrochloride

1997
Pharmacokinetically induced benzodiazepine withdrawal.
    Psychopharmacology bulletin, 2001,Autumn, Volume: 35, Issue:4

    Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Interactions; Female; Humans; Middle Aged; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride

2001
Topiramate use in alprazolam addiction.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2006, Volume: 7, Issue:4

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Fructose; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders; Topiramate; Treatment Outcome; Venlafaxine Hydrochloride

2006
Hypoglycaemia: a little known effect of Venlafaxine overdose.
    Clinical toxicology (Philadelphia, Pa.), 2012, Volume: 50, Issue:3

    Topics: Adult; Alprazolam; Analgesics; Anti-Anxiety Agents; Cyclohexanols; Depression; Drug Overdose; Drug Therapy, Combination; Female; Gastrointestinal Agents; Half-Life; Humans; Hypoglycemia; Octreotide; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Treatment Outcome; Venlafaxine Hydrochloride

2012